Skip Navigation

Cardiovascular Research 2004 63(3):443-449; doi:10.1016/j.cardiores.2004.05.004
© 2004 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Luchner, A
Right arrow Articles by Schunkert, H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luchner, A
Right arrow Articles by Schunkert, H
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2004, European Society of Cardiology

Interactions between the sympathetic nervous system and the cardiac natriuretic peptide system

A Luchner*,a and H Schunkertb

aKlinik und Poliklinik für Innere Medizin II, Klinikum der Universität Regensburg, Franz-Josef-Strauss-Allee 11, Regensburg 93042, Germany
bMedizinische Klinik II, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Lübeck 23538, Germany

* Corresponding author. Tel.: +49-941-944-7211; fax: +49-941-944-7213. Email address: andreas.luchner{at}klinik.uni-regensburg.de

The sympathetic nervous system (SNS) and the cardiac natriuretic peptide system (NPS) are fundamentally important neurohumoral systems for cardiovascular regulation. Their mutual interactions have been subject to numerous experimental and human studies. In the current manuscript, results from in vivo and in vitro studies will be reviewed with a focus on sympathetic outflow on the control of natriuretic peptide release.

KEYWORDS Sympathetic nervous system; Alpha receptor; Beta-receptor; Heart failure; ANP; Natriuretic peptides; Interactions; Cross-talk


Time for primary review 23 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
B. Geny, A. Charloux, G. Brandenberger, and F. Piquard
Despite cardiac denervation, atrial natriuretic peptides possess a cardiac sympathoinhibitory effect after heart transplantation
J. Thorac. Cardiovasc. Surg., June 1, 2006; 131(6): 1417 - 1418.
[Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
C. J. Zheng, L. Y. Han, C. W. Yap, Z. L. Ji, Z. W. Cao, and Y. Z. Chen
Therapeutic targets: progress of their exploration and investigation of their characteristics.
Pharmacol. Rev., June 1, 2006; 58(2): 259 - 279.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J. P. Goetze and R. Videbaek
More hormones spilt in heart failure: linking renal sympathetic activation to clinical outcome
Eur. Heart J., May 1, 2005; 26(9): 861 - 862.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
K.-D. Schluter and K. C Wollert
Synchronization and integration of multiple hypertrophic pathways in the heart
Cardiovasc Res, August 15, 2004; 63(3): 367 - 372.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.